CYPRESS BIOSCIENCE INC
10-Q, EX-27, 2000-08-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CYPRESS BIOSCIENCE INC, 10-Q, 2000-08-14
Next: BROADWING INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-2000
<PERIOD-START>                             APR-01-2000             JAN-01-2000
<PERIOD-END>                               JUN-30-2000             JUN-30-2000
<CASH>                                          11,132                  11,132
<SECURITIES>                                         0                       0
<RECEIVABLES>                                      676                     676
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                12,031                  12,031
<PP&E>                                             596                     596
<DEPRECIATION>                                   (414)                   (414)
<TOTAL-ASSETS>                                  12,266                  12,266
<CURRENT-LIABILITIES>                            3,238                   3,238
<BONDS>                                              0                       0
                                0                       0
                                          0                       0
<COMMON>                                           974                     974
<OTHER-SE>                                      99,275                  99,275
<TOTAL-LIABILITY-AND-EQUITY>                    12,266                  12,266
<SALES>                                              0                       0
<TOTAL-REVENUES>                                   848                   1,415
<CGS>                                              116                     180
<TOTAL-COSTS>                                    2,937                   6,502
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                 158                     294
<INCOME-PRETAX>                                (2,049)                 (5,030)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                            (2,049)                 (5,030)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                   (2,049)                 (5,030)
<EPS-BASIC>                                     (0.04)                  (0.10)
<EPS-DILUTED>                                   (0.04)                  (0.10)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission